Keryx Biopharmaceuticals Inc. (KERX) Jumps 10.93% on December 21

Equities Staff |

Keryx Biopharmaceuticals Inc. (KERX) was among the biggest gainers on the Russell 2000 for Monday December 21 as the stock popped 10.93% to $5.38, representing a gain of $0.53 per share. Some 11.13 million shares traded hands on 12,669 trades, compared with an average daily volume of 2.36 million shares out of a total float of 105.19 million. The stock opened at $4.88 and traded with an intraday range of $5.84 to $4.63.

After today's gains, Keryx Biopharmaceuticals Inc. reached a market cap of $565.94 million. Keryx Biopharmaceuticals Inc. has had a trading range between $15.13 and $3.04 over the last year, and it had a 50-day SMA of $4.82 and a 200-day SMA of $7.95.

Keryx Biopharmaceuticals Inc is a biopharmaceutical company focused on therapies for patients with renal disease. Its first product is the AuryxiaTM (ferric citrate), an oral, absorbable iron-based compound.

Keryx Biopharmaceuticals Inc. is based out of New York, NY and has some 154 employees. Its CEO is Greg Madison.

For a complete fundamental analysis analysis of Keryx Biopharmaceuticals Inc., check out’s Stock Valuation Analysis report for KERX. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Altair Resources Inc.

Altair Resources Inc, formerly Altair Gold Inc acquires, explores and develops mineral properties in Canada. The Company is in the process of exploring its mineral properties.

Private Markets


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…